News

Home>News>

Victorian development biologists are gathering in August & Cartherics joins the intellectual party

By Leigh Dayton

22 July 2021

Cartherics is delighted to announce that it is a sponsor of the Australia and New Zealand Society of Cell and Developmental Biology’s Victorian State Conference. The highly regarded one-day event is booked for 26 August at the University of Melbourne.

Cartherics CEO Alan Trounson welcomes the opportunity to support the meeting.

“It is […]

2021-07-22T12:58:44+10:00July 22nd, 2021|

Cartherics, ARMI and CCRM Australia announce new agreement for closer cooperation and collaboration

Cartherics Pty Ltd and the Australian Regenerative Medicine Institute (ARMI), including commercialisation initiative CCRM Australia, announced agreements for closer cooperation and collaboration today.

“Cartherics affiliation with ARMI is an important step in our development and will embed industry and academic excellence in regenerative medicine and translation to clinical medicine in cancer,” said Prof Alan Trounson, Cartherics […]

2021-07-05T09:56:45+10:00July 5th, 2021|

Super-Charging the Immune System to Fight Cancer

Innovative immunotherapies for cancer are a step closer to reality thanks to a commercial licence agreement between Australia’s Cartherics Pty. Ltd. and South Korea-based ToolGen, Inc.

Melbourne, Australia and Seoul, South Korea

28 June 2021

Cartherics Pty Ltd (“Cartherics”) and ToolGen, Inc. (“ToolGen”) announced today that they have entered into a commercial licence agreement.

Under the agreement, Cartherics obtains […]

2021-06-28T10:00:38+10:00June 28th, 2021|

CONGRATULATIONS TO CEO ALAN TROUNSON

Cartherics is delighted to announce that Alan Trounson has been acknowledged in today’s Queen’s Birthday 2021 Honours and Awards List

By Leigh Dayton

14 June 2021

From his early days in cattle IVF, then human IVF – as part of Australia’s first IVF team with Monash University’s Carl Wood – to his advances in embryonic stem cell research […]

2021-06-14T00:00:08+10:00June 13th, 2021|

‘Off-the-Shelf’ Immunotherapy for Ovarian Cancer

Cartherics’ CEO Alan Trounson speaks at the  BIO KOREA 2021 International Convention

By Leigh Dayton

11 June 2021

Alan Trounson joined a day-long discussion on advances in regenerative medicine. The virtual event brought together the world’s leading experts.

At the session on emerging immuno-oncology, Trounson told delegates that Cartherics believes its novel CAR-T and CAR-NK cells have great potential […]

2021-06-11T19:55:32+10:00June 11th, 2021|

Cancer survivor Heather Hawkins was devastated by news that early detection of ovarian cancer doesn’t save lives …..

But she has “unshakeable hope” that Cartherics’ innovative treatments promise an alternative path

By Heather Hawkins

24 May 2021

Ovarian Cancer: two words that changed my life forever.

Even today – and it’s been 14 years since diagnosis – they still evoke a very raw and deeply emotional response. It was the first time I’d faced the undeniable fact […]

2021-05-24T14:13:27+10:00May 24th, 2021|

Cartherics Therapies More Essential Than Ever

New research delivers devastating findings about ovarian cancer screening

Four Australian women are diagnosed with ovarian cancer a day and three will eventually die from the disease. It’s usually diagnosed late, because few women show symptoms until they have advanced cancer.

As a junior doctor in London in the mid-1980s, Ian Jacobs saw women undergo chemo and […]

2021-05-20T14:20:54+10:00May 20th, 2021|

Next Wave AntiCancer Therapies

The first in a provocative series on the complexities of advanced therapeutic approaches to cancer

By Jeff Brockman and Joel Sandler of Cello Health BioConsulting

“In 1890, the Russian playwright and physician Anton Chekov (pictured above) wrote a letter in which he alluded to a centuries-old observation that infections seemed to slow the growth of […]

2021-05-06T12:03:23+10:00May 6th, 2021|
Go to Top